A Dose-finding Phase I Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
Latest Information Update: 21 Aug 2026
At a glance
- Drugs F8 IL10 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms DekaJoint
- Sponsors Philogen
Most Recent Events
- 09 Jan 2026 Planned initiation date changed from 1 Apr 2025 to 1 Jan 2026.
- 09 Jan 2026 Status changed from not yet recruiting to recruiting.
- 15 Sep 2025 New trial record